55% af de personer, som blev behandlet med insulin detemir, fuldførte de 52 ugers behandling med et behandlingsregime på to gange daglig.
In the study versus insulin glargine, insulin detemir was allowed to be administered once or twice daily whereas insulin glargine was to be administered once a day, 55% of the insulin detemir-treated subjects completed the 52 weeks of treatment on the twice daily regimen.